It’s the Holy War between Notre Dame and Boston College for the Frank Leahy Memorial Bowl on All Saints Day. Someone call the pope and let him know what’s up. The game thread is open below. I know ...

Here’s your “Daily Open Thread” for Oct. 12, 2025. Come chat about whatever you would like. Come back all day and night for discussion of all things pro wrestling and beyond, some of the former but ...

It's been a firecracker year for JRPGs between the return of Trails in the Sky, the acclaimed Expedition 33, and the imminent remaster of Final Fantasy Tactics. It seems that the hype will keep ...

Jakob Roze, CSCS, is a health writer and high-end personal trainer. He is the founder and CEO of RozeFit, a high-end concierge personal training practice and online blog. Body-weight exercises help ...

Please provide your email address to receive an email when new articles are posted on . Adults with overweight or obesity lost significantly more weight at 72 weeks with the oral GLP-1 orforglipron vs ...

Viking Therapeutics’ VK2735 achieves a 10.9% placebo-adjusted weight loss at 13 weeks, but a less than ideal safety profile marred the results. Viking Therapeutics’ investigational obesity pill VK2735 ...

Hello, I really enjoyed reading your paper—thank you for the excellent work. Could you please share (or upload) the pretrained weights/checkpoints you used? They would be very helpful for reproducing ...

As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to an average of 27.3 pounds in the first of two pivotal trials, queuing up plans for a ...

Once-daily orforglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist, met its primary endpoint of greater weight loss compared to placebo in nondiabetic adults with obesity, or overweight ...

Even in the age of online self-diagnosis, doctors top our list of who we trust most regarding our health. Americans are six times more likely to trust their doctor than Google for health and wellness ...